Announcement of 2023 shareholders' meeting’s resolution to lift the non-competition restrictions for directors

Announcement of the Company’s important resolutions of the 2023 annual shareholders’ meeting

Announcement of By-election of the director at the 2023 Annual Shareholders’ Meeting

Announcement on behalf of Amaran of important resolutions of the 2023 annual shareholders’ meeting

Announcement on behalf of Obigen’s resolution to lift the non-competition restrictions for directors at 2023 annual shareholders’ meeting

Announcement on behalf of Obigen of important resolutions of the 2023 annual shareholders’ meeting

The COVID-19 vaccine, BCVax, has been granted by TFDA to proceed to Phase I clinical trial

Announcement of change Spokesperson

Announcement of change of CEO

Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.